Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

08/22/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

03/01/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

John Johnson

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Evolent Health (NYSE:EVH)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024

Plus de graphiques de la Bourse Evolent Health

Evolent Health (NYSE:EVH)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024

Plus de graphiques de la Bourse Evolent Health

Actualités Evolent Health Inc

Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1
Mercredi 18 Décembre 2024 ( il y a 4 jours) • PR Newswire (US)

Form 8-K - Current report
Mercredi 11 Décembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Humana and Evolent Expand Partnership to Enhance Oncology Care
Jeudi 7 Novembre 2024 ( il y a 1 mois) • Business Wire

Form 8-K - Current report
Jeudi 7 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Evolent Announces Third Quarter 2024 Results
Jeudi 7 Novembre 2024 ( il y a 1 mois) • PR Newswire (US)

Define Ventures Appoints Bruce Broussard as Venture Partner
Mardi 22 Octobre 2024 ( il y a 2 mois) • PR Newswire (US)

Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024
Vendredi 11 Octobre 2024 ( il y a 2 mois) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 27 Août 2024 ( il y a 4 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 27 Août 2024 ( il y a 4 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 27 Août 2024 ( il y a 4 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 27 Août 2024 ( il y a 4 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 27 Août 2024 ( il y a 4 mois) • Edgar (US Regulatory)

Plus d'articles sur Evolent Health Inc

WisdomTree Commodity Sec...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales